These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 18342007
21. Regulation of Th-POK and Runx3 in T cell development in human thymoma. Tokunaga T, Hayashi A, Kadota Y, Shiono H, Inoue M, Sawabata N, Okumura M. Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737 [Abstract] [Full Text] [Related]
22. Cutting edge: fine-tuning of Thpok gene activation by an enhancer in close proximity to its own silencer. Muroi S, Tanaka H, Miyamoto C, Taniuchi I. J Immunol; 2013 Feb 15; 190(4):1397-401. PubMed ID: 23315079 [Abstract] [Full Text] [Related]
23. A Fateful Decision in the Thymus Controlled by the Transcription Factor ThPOK. Egawa T. J Immunol; 2021 May 01; 206(9):1981-1982. PubMed ID: 33879577 [No Abstract] [Full Text] [Related]
24. CD4/CD8 lineage commitment: light at the end of the tunnel? He X, Kappes DJ. Curr Opin Immunol; 2006 Apr 01; 18(2):135-42. PubMed ID: 16480861 [Abstract] [Full Text] [Related]
25. An antagonist peptide mediates positive selection and CD4 lineage commitment of MHC class II-restricted T cells in the absence of CD4. Kao H, Allen PM. J Exp Med; 2005 Jan 03; 201(1):149-58. PubMed ID: 15630142 [Abstract] [Full Text] [Related]
26. Thymus lineage commitment: a single switch. Hedrick SM. Immunity; 2008 Mar 03; 28(3):297-9. PubMed ID: 18342002 [Abstract] [Full Text] [Related]
27. Thymic lineage commitment rather than selection causes genetic variations in size of CD4 and CD8 compartments. van Meerwijk JP, Bianchi T, Marguerat S, MacDonald HR. J Immunol; 1998 Apr 15; 160(8):3649-54. PubMed ID: 9558064 [Abstract] [Full Text] [Related]
31. The network of transcription factors that underlie the CD4 versus CD8 lineage decision. Naito T, Taniuchi I. Int Immunol; 2010 Oct 15; 22(10):791-6. PubMed ID: 20732858 [Abstract] [Full Text] [Related]
32. Lipid-mediated presentation of MHC class II molecules guides thymocytes to the CD4 lineage. Komaniwa S, Hayashi H, Kawamoto H, Sato SB, Ikawa T, Katsura Y, Udaka K. Eur J Immunol; 2009 Jan 15; 39(1):96-112. PubMed ID: 19089815 [Abstract] [Full Text] [Related]
33. Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment. Leung RK, Thomson K, Gallimore A, Jones E, Van den Broek M, Sierro S, Alsheikhly AR, McMichael A, Rahemtulla A. Nat Immunol; 2001 Dec 15; 2(12):1167-73. PubMed ID: 11694883 [Abstract] [Full Text] [Related]
34. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C, Okuda T, Taniuchi I. Science; 2008 Feb 08; 319(5864):822-5. PubMed ID: 18258917 [Abstract] [Full Text] [Related]
35. Directing traffic on the NKT-cell highway: a key role for ThPOK. Chakravarti S, Godfrey DI. Eur J Immunol; 2010 Sep 08; 40(9):2372-5. PubMed ID: 20809492 [Abstract] [Full Text] [Related]
36. Distinct transcriptional programs in thymocytes responding to T cell receptor, Notch, and positive selection signals. Huang YH, Li D, Winoto A, Robey EA. Proc Natl Acad Sci U S A; 2004 Apr 06; 101(14):4936-41. PubMed ID: 15044701 [Abstract] [Full Text] [Related]
38. TCR and Notch signaling in CD4 and CD8 T-cell development. Laky K, Fleischacker C, Fowlkes BJ. Immunol Rev; 2006 Feb 06; 209():274-83. PubMed ID: 16448548 [Abstract] [Full Text] [Related]
39. The role of ThPOK in control of CD4/CD8 lineage commitment. He X, Park K, Kappes DJ. Annu Rev Immunol; 2010 Feb 06; 28():295-320. PubMed ID: 20307210 [Abstract] [Full Text] [Related]